Danske Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$97M Buy
1,554,366
+53,233
+4% +$3.36M 0.19% 94
2026
Q2
$86.5M Buy
1,501,133
+55,509
+4% +$3.19M 0.17% 106
2026
Q1
$87.7M Buy
1,445,624
+223,921
+18% +$13.1M 0.21% 90
2025
Q4
$65.9M Sell
1,221,703
-365,674
-23% -$17.6M 0.15% 120
2025
Q3
$71.6M Buy
1,587,377
+262,685
+20% +$12.3M 0.18% 103
2025
Q2
$61.3M Sell
1,324,692
-327,066
-20% -$16.1M 0.15% 122
2025
Q1
$101M Buy
1,651,758
+111,006
+7% +$6.47M 0.31% 53
2024
Q4
$87.1M Buy
1,540,752
+494,973
+47% +$27.7M 0.26% 64
2024
Q3
$54.1M Buy
1,045,779
+140,990
+16% +$6.61M 0.18% 102
2024
Q2
$37.6M Sell
904,789
-162,975
-15% -$7.29M 0.14% 131
2024
Q1
$57.9M Buy
+1,067,764
New +$54.4M 0.18% 106

Other funds holding BMY

Danske Bank's BMY Position: Q3 2026 in Review

Danske Bank increased its Bristol-Myers Squibb (BMY) stake by 3.5% in Q3 2026, buying an estimated $3.36M and bringing the position to 1,554,366 shares worth $97M. The position accounts for 0.19% of the portfolio, ranked #94.

Danske Bank first reported a position in BMY in Q1 2024 and has held it in 11 quarters since. The position peaked at $101M in Q1 2025. 2,555 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Danske Bank held 1,554,366 shares of Bristol-Myers Squibb worth $97M as of Q3 2026.
  • Danske Bank bought 53,233 Bristol-Myers Squibb shares in Q3 2026, an estimated $3.36M.
  • Bristol-Myers Squibb made up 0.19% of Danske Bank's portfolio in Q3 2026, its #94 holding.
  • Danske Bank first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 11 quarters since.
  • Danske Bank's Bristol-Myers Squibb position peaked at $101M in Q1 2025.
  • 2,555 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Danske Bank's 13F filing for Q3 2026, filed 9 Nov 2026.